Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months.
Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months. Clin Gastroenterol Hepatol. 2010 Jul; 8(7):600-9.